|
Adjuvants for protein-based vaccines
|
Squalene Emulsion
|
AddaVax
|
ADJU-010CL
|
INQUIRY
|
|
SqualVax
|
ADJU-010CL-1
|
INQUIRY
|
|
Aluminum Gels
|
Alhydrogel 2%
|
ADJU-011CL
|
INQUIRY
|
|
AlumVax Hydroxide
|
ADJU-011CL-1
|
INQUIRY
|
|
AlumVax Phosphate
|
ADJU-011CL-2
|
INQUIRY
|
Freund's Adjuvant
Complete Freund’s Adjuvant
|
CFA
|
ADJU-012CL
|
INQUIRY
|
|
CFAVax
|
ADJU-012CL-1
|
INQUIRY
|
Freund's Adjuvant
Incomplete Freund's adjuvant
|
IFA
|
ADJU-013CL
|
INQUIRY
|
|
IFAVax
|
ADJU-013CL-1
|
INQUIRY
|
NLRP3 inflammasome inducer - Deacetylated derivative of chitin
Th1/Th2 response
|
Chitosan
|
ADJU-046CL
|
INQUIRY
|
|
Aluminum Gels
|
2% Aluminum hydroxide adjuvant (Vaccine adjuvant)
|
DADF-041
|
INQUIRY
|
|
Aluminum Gels
|
2% Aluminum phosphate adjuvant (Vaccine adjuvant)
|
DADF-042
|
INQUIRY
|
|
Calcium phosphate
|
Calcium phosphate adjuvant (Vaccine adjuvant)
|
DADF-043
|
INQUIRY
|
|
Freunds Adjuvant
|
Classical Adjuvant Combo Pak-1 (contains 10 ml each CFA (#DAGF-051), IFA (#DAGF-053), and Squalene (#DAGF-055)
|
DADF-050
|
INQUIRY
|
|
Complete Freunds Adjuvant
|
Complete Freunds Adjuvant (CFA, Vaccine adjuvant)
|
DADF-051
|
INQUIRY
|
|
Incomplete Freunds Adjuvant
|
Incomplete Freunds Adjuvant (IFA, Vaccine adjuvant)
|
DADF-053
|
INQUIRY
|
|
Quillaja saponaria
|
Quillaja saponaria (>95%, EU GMP grade, Vaccine adjuvant)
|
DADF-054
|
INQUIRY
|
|
Squalene
|
Squalene (oil-in-water nano emulsion, Vaccine adjuvant)
|
DADF-055
|
INQUIRY
|
|
Vet-SAP
|
Vet-SAP (>95%, EU GMP grade, Vaccine adjuvant)
|
DADF-057
|
INQUIRY
|
|
Peanut Oil
|
Peanut Oil (vaccine adjuvant)
|
DADF-060
|
INQUIRY
|
|
Mineral Oil
|
Mineral Oil (vaccine adjuvant)
|
DADF-061
|
INQUIRY
|
|
Mannide monooleate
|
Mannide monooleate (vaccine adjuvant)
|
DADF-062
|
INQUIRY
|
|
HS15 Kolliphore
|
HS15 Kolliphore vaccine adjuvant
|
DADF-063
|
INQUIRY
|
|
TLR5 agonist
|
Recombinant flagellin FlicC (TLR5 agonist, vaccine adjuvant)
|
DADF-065
|
INQUIRY
|
|
MPLA
|
Monophosphoryl lipid A (MPLA) (Synthetic, TLR4/Th1, vaccine adjuvant)
|
DADF-069
|
INQUIRY
|
|
Diphosphoryl Lipid A
|
Diphosphoryl Lipid A (E. coli K12 D31m4)
|
DADF-070
|
INQUIRY
|
|
Tetani toxin Light-chain
|
Recombinant purified tetani toxin Light-chain (Non toxic)
|
DADF-074
|
INQUIRY
|
|
Tetani toxin
|
Recombinant purified (P. fluorescens) low endotoxin tetani toxin C-terminal fragment (52 KDa, >95%)
|
DADF-077
|
INQUIRY
|
|
Diphtheria Toxoid
|
Purified Diphtheria Toxoid protein (antigen grade)
|
DADF-080
|
INQUIRY
|
|
Pam2CSK4
|
Pam2CSK4 vaccine adjuvant, unlabeled
|
DADF-082
|
INQUIRY
|
|
Diphtheria Toxoid
|
Purified Diphtheria Toxoid protein (antigen grade)
|
DADF-083
|
INQUIRY
|
|
CRM197
|
Purified CRM197 (Diphtheria Toxin mutant) protein (vaccine grade)
|
DADF-086
|
INQUIRY
|
|
RWJ 21757
|
RWJ 21757 Synthetic (vaccine adjuvant)
|
DADF-087
|
INQUIRY
|
|
TDB
|
TDB (Trehalose-6,6-dibehenate) Synthetic (vaccine adjuvant)
|
DADF-088
|
INQUIRY
|
|
Pam2CSK4
|
Pam2CSK4 (vaccine adjuvant) [Biotin]
|
DADF-089
|
INQUIRY
|
|
Cholera Toxin
|
Purified Cholera Toxin protein (vaccine grade)
|
DADF-092
|
INQUIRY
|
|
PRR Ligands-based adjuvant
|
STING ligand - Cyclic [G(3’,5’)pA(3’,5’)p]
|
3’3’-cGAMP
|
ADJU-014CL
|
INQUIRY
|
|
STING ligand - Cyclic [G(2’,5’)pA(3’,5’)p]
|
2’3’-cGAMP
|
ADJU-015CL
|
INQUIRY
|
|
STING ligand - Cyclic [G(2’,5’)pA(2’,5’)p]
|
2’2’-cGAMP
|
ADJU-016CL
|
INQUIRY
|
STING ligand - CDS agonist - Cyclic diadenylate monophosphate
Th1 / Th2 response
|
c-di-AMP
|
ADJU-017CL
|
INQUIRY
|
STING ligand - CDS agonist - Cyclic diguanylate monophosphate
Th1 / Th2 response
|
c-di-GMP
|
ADJU-018CL
|
INQUIRY
|
NOD2 Agonist - N-glycolylated muramyldipeptide
Th1 response
|
N-Glycolyl-MDP
|
ADJU-019CL
|
INQUIRY
|
Mincle agonist - Synthetic analog of the cord factor
Th1 response
|
TDB
|
ADJU-020CL
|
INQUIRY
|
Mincle agonist - Synthetic analog of the cord factor formulated with HS15
Th1 response
|
TDB-HS15
|
ADJU-021CL
|
INQUIRY
|
TLR1/2 agonist - Synthetic triacylated lipoprotein
Th1 response
|
Pam3CSK4
|
ADJU-022CL
|
INQUIRY
|
TLR3 agonist - Polyinosine-polycytidylic acid
Th1 response
|
Poly(I:C) (HMW)
|
ADJU-023CL
|
INQUIRY
|
|
Lipopolysaccharide from E. coli 0111:B4 strain - TLR4-based adjuvant
|
LPS-EB
|
ADJU-024CL
|
INQUIRY
|
TLR4 agonist - Monophosphoryl lipid A
Th1 response
|
MPLA-SM
|
ADJU-025CL
|
INQUIRY
|
TLR4 agonist - Synthetic monophosphoryl lipid A
Th1 response
|
MPLA Synthetic
|
ADJU-026CL
|
INQUIRY
|
TLR5 Agonist - Recombinant flagellin
Th1/Th2 response
|
Flagellin FliC
|
ADJU-027CL
|
INQUIRY
|
TLR7 agonist - Imidazoquinoline compound
Th1 response
|
Gardiquimod
|
ADJU-028CL
|
INQUIRY
|
TLR7 agonist - Imidazoquinoline compound
Th1 response
|
Imiquimod
|
ADJU-029CL
|
INQUIRY
|
TLR7/8 agonist - Imidazoquinoline compound
Th1 response
|
R848
|
ADJU-030CL
|
INQUIRY
|
TLR9 agonist - CpG ODN, class A (murine)
Th1 response
|
ODN 1585
|
ADJU-031CL
|
INQUIRY
|
TLR9 agonist - CpG ODN, class B (murine)
Th1 response
|
ODN 1826
|
ADJU-032CL
|
INQUIRY
|
TLR9 agonist - CpG ODN, class B (human)
Th1 response
|
ODN 2006
|
ADJU-033CL
|
INQUIRY
|
TLR9 agonist - CpG ODN, class C (human/mouse)
Th1 response
|
ODN 2395
|
ADJU-034CL
|
INQUIRY
|
|
LPS
|
Lipopolysaccharides (LPS) (Escherichia coli 0111:B4, vaccine adjuvant)
|
DADF-066
|
INQUIRY
|
|
LPS
|
Ultrapure Lipopolysaccharides (LPS) (Escherichia coli 0111:B4, TLR4 tested, vaccine adjuvant)
|
DADF-067
|
INQUIRY
|
|
LPS
|
Lipopolysaccharides (LPS) (Salmonella typhimurium, vaccine adjuvant)
|
DADF-068
|
INQUIRY
|
|
Peptidoglycan
|
Peptidoglycan (S. aureus, vaccine adjuvant)
|
DADF-071
|
INQUIRY
|
|
MPLA
|
Monophosphoryl lipid A (MPLA)-SM (S. enterica Minnesota, R595, vaccine adjuvant)
|
DADF-072
|
INQUIRY
|
|
TLR7 agonist
|
Gardiquimod (TLR7 agonist/Imidazoquinoline), antigen grade
|
DADF-075
|
INQUIRY
|
|
MDP
|
MDP, muramyldipetide (Ac-muramyl-Ala-D-Glu-amide) Synthetic (vaccine adjuvant)
|
DADF-076
|
INQUIRY
|
|
TLR7 agonist
|
Imiquimod (TLR7 agonist/Imidazoquinoline), antigen grade
|
DADF-078
|
INQUIRY
|
|
TLR7/8 agonist
|
Resiquimod (Imidazoquinoline compound)-TLR7/8 agonist, antigen grade
|
DADF-079
|
INQUIRY
|
